Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 30% ± 14% | |
peripheral blood | 12 studies | 30% ± 9% | |
kidney | 8 studies | 26% ± 6% | |
intestine | 7 studies | 29% ± 12% | |
lymph node | 6 studies | 29% ± 12% | |
eye | 5 studies | 25% ± 11% | |
bone marrow | 5 studies | 23% ± 3% | |
brain | 5 studies | 22% ± 5% | |
liver | 5 studies | 30% ± 17% | |
pancreas | 4 studies | 38% ± 18% | |
uterus | 4 studies | 35% ± 15% | |
breast | 4 studies | 32% ± 5% | |
placenta | 3 studies | 34% ± 13% | |
adrenal gland | 3 studies | 24% ± 6% | |
prostate | 3 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1980.26 | 180 / 180 | 100% | 151.51 | 430 / 430 |
brain | 100% | 1727.20 | 2640 / 2642 | 100% | 81.59 | 705 / 705 |
pancreas | 100% | 1220.34 | 327 / 328 | 100% | 51.43 | 178 / 178 |
skin | 100% | 2684.04 | 1809 / 1809 | 100% | 87.40 | 470 / 472 |
esophagus | 100% | 2205.65 | 1445 / 1445 | 99% | 49.83 | 182 / 183 |
breast | 100% | 2034.90 | 459 / 459 | 99% | 83.50 | 1111 / 1118 |
thymus | 100% | 1585.84 | 653 / 653 | 99% | 63.93 | 601 / 605 |
intestine | 100% | 1583.59 | 966 / 966 | 99% | 87.73 | 523 / 527 |
uterus | 100% | 1894.30 | 170 / 170 | 99% | 77.59 | 455 / 459 |
stomach | 100% | 1374.62 | 359 / 359 | 99% | 78.11 | 283 / 286 |
prostate | 100% | 1690.74 | 245 / 245 | 99% | 76.85 | 496 / 502 |
lung | 100% | 1409.00 | 576 / 578 | 99% | 56.02 | 1145 / 1155 |
bladder | 100% | 1957.86 | 21 / 21 | 99% | 78.13 | 497 / 504 |
liver | 100% | 1002.36 | 225 / 226 | 99% | 50.60 | 400 / 406 |
kidney | 100% | 1687.31 | 89 / 89 | 98% | 50.47 | 883 / 901 |
adrenal gland | 100% | 1799.75 | 258 / 258 | 97% | 53.23 | 222 / 230 |
adipose | 100% | 1822.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 97.72 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 114.02 | 29 / 29 |
spleen | 100% | 1404.02 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 74.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.66 | 1 / 1 |
blood vessel | 100% | 1709.08 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1521.26 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1278.49 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 1274.19 | 818 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_0031118 | Biological process | rRNA pseudouridine synthesis |
GO_0031120 | Biological process | snRNA pseudouridine synthesis |
GO_0007004 | Biological process | telomere maintenance via telomerase |
GO_0005732 | Cellular component | sno(s)RNA-containing ribonucleoprotein complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031429 | Cellular component | box H/ACA snoRNP complex |
GO_0072589 | Cellular component | box H/ACA scaRNP complex |
GO_0090661 | Cellular component | box H/ACA telomerase RNP complex |
GO_0005697 | Cellular component | telomerase holoenzyme complex |
GO_0070034 | Molecular function | telomerase RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0034513 | Molecular function | box H/ACA snoRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | NHP2 |
Protein name | H/ACA ribonucleoprotein complex subunit 2 H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2) |
Synonyms | NOLA2 HSPC286 |
Description | FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. . FUNCTION: Common component of the spliceosome and rRNA processing machinery. .; FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. . FUNCTION: Common component of the spliceosome and rRNA processing machinery. .; FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. . FUNCTION: Common component of the spliceosome and rRNA processing machinery. .; FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. . |
Accessions | ENST00000314397.9 ENST00000511078.1 Q9NX24 D6RCB9 ENST00000514354.5 D6RC52 ENST00000274606.8 J3QSY4 |